After completing the first phase of IPO allocation for Nepalese workers abroad. Om Megashree Pharmaceuticals Limited has opened its Initial Public Offering (IPO) for the general public starting today, 27th Falgun, 2081.
The company is issuing 14,76,000 unit shares at a par value of Rs. 100 per share. The early closing date for the IPO is 3rd Chaitra, 2081, with a possible extension to 12th Chaitra, 2081, if the issue remains unsubscribed.
Key Highlights of the IPO
IPO Details and Allocation
- Total Issued Capital: Rs. 60 Crores.
- Public Issue: 30% (18,00,000 units worth Rs. 18 Crores).
- Nepalese Citizens Working Abroad: 10% (1,80,000 units).
- Mutual Funds: 5% (90,000 units).
- Company Employees: 3% (54,000 units).
- General Public: 14,76,000 units (remaining 82%).
Issue Manager
Prabhu Capital Limited has been appointed as the issue manager for the IPO. They will oversee the application process and ensure compliance with regulatory requirements.
CARE Ratings Nepal’s Reaffirmation
CARE Ratings Nepal Limited (CRNL) has reaffirmed the following ratings for Om Megashree Pharmaceuticals Limited:
- Issuer Rating: ‘CARE-NP BB- (Is)’ – indicating a moderate risk of default in meeting financial obligations.
- Long-term Bank Facilities: ‘CARE-NP BB-’.
- Short-term Bank Facilities: ‘CARE-NP A4’.
These ratings reflect the company’s financial stability and operational capabilities.
About Om Megashree Pharmaceuticals Limited
- Establishment: June 12, 2016.
- Type: Public Limited Company.
- Operations: Manufacturing pharmaceutical products at its plant in Chitwan.
- Partial Operations Started: February 19, 2024.
Conclusion
Om Megashree Pharmaceuticals Limited’s IPO presents an opportunity for the general public to invest in a growing pharmaceutical company with a strong foundation. With a moderate default risk rating and a clear allocation plan, the IPO is poised to attract investor interest. Interested individuals can apply for shares starting today, 27th Falgun, 2081, through the designated issue manager, Prabhu Capital Limited.
